Biocardia sets price for IPO

BioCardia, which is due for its IPO on Monday, plans to raise $50 million by offering 3.85 million shares at a price range of $12 to $14. At the midpoint of the proposed range, BioCardia would command a fully diluted market value of $154 million.

BioCardia will be Listed on the NASDAQ under the symbol BCDA.